Decoding India’s Covid Vaccine Approvals with Kiran Mazumdar-Shaw: Part II

Kiran Mazumdar-Shaw Shaw spoke to Barkha Dutt, editor of Mojo, addressing doubts around India's COVID-19 vaccines rollout, on whether India's two approved vaccines are safe, what the difference is in the approval to the Serum Institute and Bharat Biotech vaccines and who should get the vaccines first. Here's Part 2 of the interview. Barkha: Are … Continue reading Decoding India’s Covid Vaccine Approvals with Kiran Mazumdar-Shaw: Part II

Decoding India’s two approved vaccines and looking at the rollout with Kiran Mazumdar Shaw

Kiran Mazumdar-Shaw Shaw spoke to Barkha Dutt, editor of Mojo, addressing doubts around India's COVID-19 vaccines rollout, on whether India's two approved vaccines are safe, what the difference is in the approval to the Serum Institute and Bharat Biotech vaccines and who should get the vaccines first. Here's Part 1 of the interview. Barkha Dutt: … Continue reading Decoding India’s two approved vaccines and looking at the rollout with Kiran Mazumdar Shaw

Indian regulator has granted Emergency Approval to Covaxin, Covishield based on strong scientific judgment.

India’s health regulator Drugs Controller General of India (DCGI) has granted Emergency Use Authorization (EUA) to two vaccines, Covaxin andCovishield , to fight the COVID-19 pandemic. Covaxin has been developed by Bharat Biotech in collaboration with the Indian Council for Medical Research (ICMR) and National Institute of Virology (NIV). Covishield has been developed by Oxford … Continue reading Indian regulator has granted Emergency Approval to Covaxin, Covishield based on strong scientific judgment.

India needs to inoculate a million people a day against COVID-19

India's health regulator Drugs Controller General of India (DCGI) has granted permission to two vaccines, Covishield and Covaxin, for "restricted use" in an emergency situation to fight the COVID-19 pandemic. Covishield has been developed by Oxford University scientists in collaboration with pharmaceutical company AstraZeneca. In India, its trial was undertaken by the Serum Institute of … Continue reading India needs to inoculate a million people a day against COVID-19

World needs to balance risks, benefits and challenges of deploying COVID-19 vaccines

Biocon Executive Chairperson Kiran Mazumdar-Shaw recently spoke at Carnegie India’s Global Technology Summit, which convened leading policymakers, entrepreneurs, industry leaders, academics and technologists from around the world to deliberate over five days on an overarching theme of ‘Geopolitics of Technology’. On Dec. 18, 2020, the last day of the summit, Ms Mazumdar-Shaw joined Soumya Swaminathan, … Continue reading World needs to balance risks, benefits and challenges of deploying COVID-19 vaccines

India Has Potential to Increase Covid Testing 10-Fold, Kiran Mazumdar-Shaw Says

India has the ability to aggressively ramp up coronavirus testing capacity, a move that will help it check a wave of new active cases hitting hospitals and skirt an economically unviable lockdown, according to Ms. Kiran Mazumdar-Shaw, the founder and chairman of Biocon Ltd.  With pooled testing that can include as many as 10 people in one … Continue reading India Has Potential to Increase Covid Testing 10-Fold, Kiran Mazumdar-Shaw Says

#Podcast: Compassionate Capitalism, with Kiran Mazumdar-Shaw by Milken Institute

In a recent talk with Mike Milken from the Milken Institute, Kiran Mazumdar-Shaw shared her views on Compassionate Capitalism while talking about "Responding to Covid-19". “I'm very committed to compassionate capitalism, which is what I like to call my business....My products are there to help patients who need it anywhere in the world. And therefore, … Continue reading #Podcast: Compassionate Capitalism, with Kiran Mazumdar-Shaw by Milken Institute

A ‘Contain, Control, Cascade’ Mantra to Tackle Our COVID-19 Crisis

By Kiran Mazumdar-Shaw, Executive Chairperson, Biocon The first COVID-19 case in Karnataka was reported on March 9. Strict containment measures ensured the total number of cases were contained to approximately 3,200, with 1,950 active cases and just over 50 deaths till May 31 when the nationwide lockdown started to be eased. Since then the situation … Continue reading A ‘Contain, Control, Cascade’ Mantra to Tackle Our COVID-19 Crisis